DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to announce Dr. Moe Afaneh, Pharm D., MBA, NRCC, RNC has just been appointed as Chief Operations Officer for the company. Dr. Afaneh’s first and immediate mandate is to bring the Cannabis Science product line to the national market through his personal expertise and industry relationships. Dr. Afaneh will serve as an asset to Cannabis Science by improving the overall efficiency and quality of its national pharmaceutical operations and penetrating new national markets.